Gvanklofin
Nazivi | |
---|---|
IUPAC naziv 2-[2-(2,6-dihloroanilino)etil]gvanidin | |
Drugi nazivi (2-(2,6-dihloroanilino)etil)gvanidin | |
Identifikacija | |
| |
3D model (Jmol) |
|
| |
UNII |
|
SMILES
| |
Svojstva | |
C9H12Cl2N4 | |
Molarna masa | 247,12 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
Gvanklofin je antagonist beta adrenergičkog receptora.[3]
Reference
- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ E Glusa; F Markwardt; B Förster (1982). „Effect of guanclofin on catecholamine release by the adrenal medulla”. Farmakol Toksikol. 45 (4): 27—30.
- п
- р
- у
Adrenergici
|
|
|
Drugi | |||||||
---|---|---|---|---|---|---|---|
|